Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Long-term Safety and Effectiveness of Laser in Situ Keratomileusis (LASIK) in Combination With Corneal UV-riboflavin Crosslinking in Comparison With Classic LASIK for the Correction of Myopia and Myopic Astigmatism

NCT06857032 is registered in ClinicalTrials.gov with University Clinic Frankfurt as lead sponsor.

NCT NCT06857032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Long-term Safety and Effectiveness of Laser in Situ Keratomileusis (LASIK) in Combination With Corneal UV-riboflavin Crosslinking in Comparison With Classic LASIK for the Correction of Myopia and Myopic Astigmatism
Lead sponsor
University Clinic Frankfurt
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 1, 2024
Completion date
December 31, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal biomechanics, endothelial cells, iop, manifest ref, optical coherence tomography, tomography